Tuberculosis and Respiratory Diseases

  • 제75권4호
  • /
  • Pages.165-169
  • /
  • 2013
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지
DOI QR코드

DOI QR Code

A Case of Recurrent Pulmonary Inflammatory Myofibroblastic Tumor with Aggressive Metastasis after Complete Resection

  • Moon, Chae Ho (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Yoon, Jong Ho (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kang, Geon Wook (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Lee, Seong Hyeon (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Baek, Jeong Su (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kim, Seo Yun (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kim, Hye-Ryoun (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences) ;
  • Kim, Cheol Hyeon (Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences)
  • 투고 : 2013.06.18
  • 심사 : 2013.08.01
  • 발행 : 2013.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

An inflammatory myofibroblastic tumor (IMT) is a rare disease entity reported to arise in various organs. It is thought to be a neoplastic or reactive inflammatory condition, controversially. The treatment of choice for myofibroblastic tumor is surgery, and recurrence is known to be rare. The optimal treatment method is not well-known for patients ineligible for surgery. We report a 47-year-old patient with aggressive recurrent IMT of the lungs. The patient had been admitted for an evaluation of back-pain two years after a complete resection of pulmonary IMT. Radiation therapy was performed for multiple bone recurrences, and the symptoms were improved. However the patient presented again with aggravated back-pain six months later. High-dose steroid and non-steroidal anti-inflammatory drugs were administered, but the disease progressed aggressively, resulting in spinal cord compression and metastasis to intra-abdominal organs. This is a very rare case of aggressively recurrent pulmonary IMT with multi-organ metastasis.

키워드

참고문헌

  1. Cerfolio RJ, Allen MS, Nascimento AG, Deschamps C, Trastek VF, Miller DL, et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999;67:933-6. https://doi.org/10.1016/S0003-4975(99)00155-1
  2. Hagenstad CT, Kilpatrick SE, Pettenati MJ, Savage PD. Inflammatory myofibroblastic tumor with bone marrow involvement: a case report and review of the literature. Arch Pathol Lab Med 2003;127:865-7.
  3. Kim DY, Park HS, Kim SM, Park JH, Hong YS, Lee JL, et al. Inflammatory myofibroblastic tumor showing durable remission after anthracycline-containing cytotoxic chemotherapy: report of a case. Korean J Med 2012;82:749-53. https://doi.org/10.3904/kjm.2012.82.6.749
  4. Sasagawa Y, Akai T, Itou S, Iizuka H. Multiple intraosseous inflammatory myofibroblastic tumors presenting with an aggressive clinical course: case report. Neurosurgery 2011;69:E1010-5. https://doi.org/10.1227/NEU.0b013e318223b651
  5. Brunn H. Two interesting benign lung tumors of contradictory histopathology. J Thorac Surg 1939;9:119-31.
  6. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CD, Unni KK, Mertens F, editors. World Health Organization classification of tumours: pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press; 2002. p. 91-3.
  7. Coffin CM, Patel A, Perkins S, Elenitoba-Johnson KS, Perlman E, Griffin CA. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001;14:569-76. https://doi.org/10.1038/modpathol.3880352
  8. Suetsugu S, Yamamoto H, Izumi M, Takayama K, Inoue H, Nakanishi Y. A case of rapidly growing inflammatory myofibroblastic tumor in the lung. Nihon Kokyuki Gakkai Zasshi 2009;47:1156-60.
  9. Kubo N, Harada T, Anai S, Otsubo K, Yoneshima Y, Ijichi K, et al. Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor. Intern Med 2012;51:2399-401. https://doi.org/10.2169/internalmedicine.51.7599
  10. Applebaum H, Kieran MW, Cripe TP, Coffin CM, Collins MH, Kaipainen A, et al. The rationale for nonsteroidal antiinflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study. J Pediatr Surg 2005;40:999-1003. https://doi.org/10.1016/j.jpedsurg.2005.03.016

피인용 문헌

  1. Inflammatory myofibroblastic tumor: a rare tumor of the lung vol.1, pp.1, 2013, https://doi.org/10.3402/ecrj.v1.25390
  2. Recurrent inflammatory myofibroblastic tumor of the inguinal region: A case report and review of the literature vol.10, pp.2, 2013, https://doi.org/10.3892/ol.2015.3297
  3. Pulmonary inflammatory myofibroblastic tumor: a case report vol.26, pp.4, 2013, https://doi.org/10.1177/0218492318770845
  4. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib : A case report vol.98, pp.52, 2013, https://doi.org/10.1097/md.0000000000018414
  5. Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung vol.10, pp.None, 2013, https://doi.org/10.3389/fonc.2020.00673